can you take ivermectin with semaglutide Weight-loss drug Wegovy produces 'largest benefit ever seen' for patients most common form of heart failure, trial finds Woman shares journey of weight

With the anti-obesity pharmacotherapy landscape rapidly evolving, two investigational agents from Eli Lilly have recently demonstrated highly promising Phase 2 results: Retatrutide (LY3437943) and Eloralintide (LY3841136)

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

Startups are raising millions to build businesses around drugs like Ozempic and Wegovy, as they chase a market set to surge to $90 billion.

Fella Health reviewed: provider credentialing, pharmacy sourcing, clinical oversight, and program transparency

MeAgain reveals practical tips for choosing the right GLP-1.

Benzonatate can be used cautiously in this patient with pulmonary emphysema and dyspnea on exertion, but it should NOT be first-line therapy and requires car...